Avita Medical
RCEL
84 hedge funds and large institutions have $98.2M invested in Avita Medical in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 17 increasing their positions, 27 reducing their positions, and 18 closing their positions.
120% more call options, than puts
Call options by funds: $538K | Put options by funds: $244K
22% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 18
5% more funds holding
Funds holding: 80 → 84 (+4)
3.84% less ownership
Funds ownership: 31.86% → 28.01% (-3.8%)
17% less capital invested
Capital invested by funds: $119M → $98.2M (-$20.6M)
37% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$5.7M |
| 2 |
BlackRock
New York
|
+$1.02M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$596K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$368K |
| 5 |
State Street
Boston,
Massachusetts
|
+$357K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$4.22M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$3.64M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.28M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$3.08M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.41M |
RCEL Hedge Fund Activity: Q4 2023 in Review
84 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2023, worth a combined $98.2M — down 17% from $119M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new RCEL positions and 18 closed out — a net gain of 4 holders — while 17 added to existing stakes and 27 trimmed.
The largest buyer was AWM Investment Company, opening a new position worth an estimated $5.7M. The largest seller was Russell Investments Group, cutting an estimated $4.22M.
- 84 institutional investors held Avita Medical (RCEL) as of Q4 2023, up from 80 in Q3 2023.
- Funds reported $98.2M of Avita Medical stock for Q4 2023, down 17% quarter-over-quarter.
- 22 funds opened new Avita Medical positions in Q4 2023 and 18 closed out, a net change of +4 holders.
- The largest Avita Medical buyer in Q4 2023 was AWM Investment Company, an estimated $5.7M added.
- The largest Avita Medical seller in Q4 2023 was Russell Investments Group, an estimated $4.22M sold.
Based on aggregated 13F filings for Q4 2023.